Navigation Links
EAU Technologies to Present at AeA Micro Cap Conference

ATLANTA, April 30 /PRNewswire/ -- EAU Technologies, a leading provider of Electrolyzed Water - EMPOWERED WATER(TM) - for high-volume, business-to- business applications, today announced that Wade Bradley, President and CEO, will be presenting at the 10th Annual AeA Micro Cap Financial Conference to be held at the Monterey Plaza Hotel in Monterey, CA on May 6, 2008. Mr. Bradley will review the company's corporate strategy, strengths and trends currently impacting the business.

This year, for the first time, the AeA conference will feature a track on alternative energy/green tech companies with a panel discussion, "Investing in Innovative Clean Tech Solutions," hosted by Needham & Company, LLC.

The AeA Micro Cap Financial Conference showcases public technology companies up to $200 million in market cap or revenues. AeA is the nation's largest high-tech trade association and its Micro Cap Financial Conference is held each spring in Monterey, CA. Its unique, neutral format allows executives from more than 100 technology companies and more than 250 investors to pair off for intimate small group discussions around technologies, strategic missions, trend analyses and investment potential.

About EAU:

EAU Technologies, Inc. (EAU) is a supplier of Electrolyzed Water Technology (EW Technology marketed as Empowered Water(TM)) and other complementary technologies with applications in diverse industries. EAU's water-based and non-toxic solutions (at application concentration, the solutions are non-toxic to humans and live animals) may replace many of the traditional methods now used to clean, disinfect and nourish in large industries such as agriculture and food processing. EAU has solutions for existing bacteria, virus and mold proliferation threats. EAU continues to add innovative and efficacious products that offer a systemic approach to pathogen elimination in food processing plants and related industries, thereby producing safer foods while protecting the environment through "Green Technology." EAU has developed patent pending systems that are being used on dairies to process drinking water for dairy herds. Studies and trials are showing promising results at improving animal digestion which shows signs of improved animal health and production. EAU uses terms like "green", "natural", "non-toxic" and "organic" based on our NAMSA studies that show no toxicity or cytotoxicity at levels as high as 70 ppm of HOCl. EAU uses only water, food grade electrolytes and electricity to create all of its solutions. The active ingredients in the solutions EAU creates through electrolysis are GRAS (generally regarded as safe) approved. Please visit our website and sign up to be emailed our press releases and public announcements.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward- looking statements may include without limitation, our expectations about the growth and the potential for the company, and Mr. Bradley's abilities to lead the company in that growth. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk associated with successfully developing our business in evolving markets, our need for additional capital, our continuing operating losses, the ability of our management to conduct distribution activities and sell products, possible failure to successfully develop new products, vulnerability to competitors due to lack of patents on our products, and other risk factors listed in our annual report on Form 10-KSB for the year ended December 31, 2005 and our other SEC reports. Forward-looking statements may be identified by terms such as "may," "will," "should," "could, " "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.

About AeA

AeA, the nation's largest technology trade association representing all segments of the high-tech industry, is dedicated solely to helping our members' top line and bottom line. We do this in partnership with our small, medium, and large member companies by lobbying governments at the state, federal, and international levels, providing access to capital and business opportunities, and offering select business services and networking programs. For more information, please visit .

SOURCE EAU Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Intronis Technologies to Launch Partner Enablement Program at INTEROP 2008
2. VNUS Medical Technologies, Inc. Announces Availability of Investor Presentation on Its IR Site
3. First-Quarter 2008 Results Teleconference/Webcast for VNUS Medical Technologies Interrupted Due to Technical Difficulties
4. Global Med Technologies(R), Inc. to Present at Inaugural LD MICRO Conference at the Omni Hotel in Los Angeles
5. Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
6. Accenx Technologies Announces New Leadership in Sales and Marketing Division
7. VNUS Medical Technologies, Inc. Announces the Hiring of Don Todd as Vice President of Marketing
8. Measuring medicine: How new technologies could help doctors predict patient outcomes
9. Breakaway Technologies Celebrates 10 Years in Business
10. Intronis Technologies eSureIT Partner Program Certified Gold By CMP Channels VARBusiness
11. Greenway Medical Technologies Experiences Continued Growth in OB/GYN Marketplace
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... Speech and physical therapies are traditionally conducted ... and under the right circumstances, these practices can be merged. This combination ... his or her therapeutic sessions, as well as gives the physical and speech ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... Libertyville, IL (PRWEB) , ... December 01, 2015 ... ... catheters, keeping their independence is everything. That is why Hollister Incorporated has launched ... excited to offer this next product in the VaPro touch free catheter portfolio,” ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of ... latest addition to the devices for sale in the United States. Clarity is ... long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy to own ...
(Date:12/1/2015)... , ... December 01, 2015 , ... With FCPX ... and with full control over customization, the possibilities are truly endless, all with a ... randomization, overlay depth position, vertical flip, horizontal flip, depth of field and more, all ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel ... the company will present at the LD Micro Main Event. ... Sunset Boulevard Hotel in Los Angeles, CA. ... present on Thursday, December 3, at 9:00 am Pacific time ... at least 10 minutes prior to the start of the ...
(Date:12/1/2015)... Dec. 1, 2015   MabVax Therapeutics Holdings, Inc ... announces it has filed an Investigational New Drug Application ... for the Company,s lead fully human antibody product HuMab ... MabVax plans to initiate the Phase I clinical trial ... --> The planned Phase I trial will ...
(Date:12/1/2015)... 2015   Craneware, Inc ., the healthcare ... announced the company will showcase a new version ... solution at the American Society for Health-System ... The new features are focused on simplifying and ... managing enterprise-wide pharmacy charges to ensure compliance and ...
Breaking Medicine Technology: